Drug name - Tiglutik Kit

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765150 ITALFARMACO SPA Riluzole aqueous suspensions Mar, 2029

(6 years from now)

Drugs and Companies using RILUZOLE ingredient

Treatment: A method of treating amyotrophic lateral sclerosis in a patient in need of such treatment, said method comprising administering to said patient an effective amount of a suspension according to claim 1

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
50MG/10ML SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.